|
|
|
Volumn 84 Suppl EHA-4, Issue , 1999, Pages 46-49
|
|
Cytomegalovirus infection following stem cell transplantation.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
ANTIVIRUS AGENT;
CIDOFOVIR;
CYTOSINE;
DRUG DERIVATIVE;
FOSCARNET;
GANCICLOVIR;
ORGANOPHOSPHORUS COMPOUND;
PHOSPHONIC ACID DERIVATIVE;
VIRUS ANTIBODY;
ADOPTIVE IMMUNOTHERAPY;
BLOOD;
BLOOD DONOR;
BLOOD TRANSFUSION;
CYTOMEGALIC INCLUSION BODY DISEASE;
CYTOMEGALOVIRUS;
DISEASE TRANSMISSION;
DONOR;
HEMATOPOIETIC STEM CELL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOLOGY;
ISOLATION AND PURIFICATION;
LEUKOCYTE TRANSFUSION;
PHYSIOLOGY;
PREMEDICATION;
REVIEW;
RISK FACTOR;
VIROLOGY;
VIRUS LATENCY;
ACYCLOVIR;
ANTIBODIES, VIRAL;
ANTIVIRAL AGENTS;
BLOOD DONORS;
BLOOD TRANSFUSION;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTIONS;
CYTOSINE;
FOSCARNET;
GANCICLOVIR;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMATOPOIETIC STEM CELLS;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOTHERAPY, ADOPTIVE;
LEUKOCYTE TRANSFUSION;
ORGANOPHOSPHORUS COMPOUNDS;
PHOSPHONIC ACIDS;
PREMEDICATION;
RISK FACTORS;
TISSUE DONORS;
VIRUS LATENCY;
|
|
EID: 0033139444
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (19)
|
|
References (13)
|
